ARIA Associated with Aducanumab
Dr. Jeff Burns talks with Dr. Lon Schneider about the development of ARIA in the Phase 3 EMERGE and ENGAGE trials that led to the FDA's accelerated approval of aducanumab for the treatment of Alzheimer disease.
You May Also Like
Daily Motivations
Tolulope Akodu
Be Calm and Relaxed with Rain and Thunder for Sleeping
ColoredJuice Podcast Studio
Good Thinking: Positive Affirmations
Just Curious Media
schlank + gesund mit Patric Heizmann
Patric Heizmann
The Rainbow Path Society
Dr.John Allen Reilly and Pr.Cristoforo Padula
Forensic Psychology
Circle Of Insight Productions
The Anxiety Coaches Podcast
Gina Ryan
Daily Meditation
Daily Meditation Club
"Mindful Moments: Daily Breathing Exercises for Relaxation"
Liquid Studios
Calm Raindrops
Sol Good Network
Daily Motivations
Tolulope Akodu
Be Calm and Relaxed with Rain and Thunder for Sleeping
ColoredJuice Podcast Studio
Good Thinking: Positive Affirmations
Just Curious Media
schlank + gesund mit Patric Heizmann
Patric Heizmann
The Rainbow Path Society
Dr.John Allen Reilly and Pr.Cristoforo Padula
Forensic Psychology
Circle Of Insight Productions
The Anxiety Coaches Podcast
Gina Ryan
Daily Meditation
Daily Meditation Club
"Mindful Moments: Daily Breathing Exercises for Relaxation"
Liquid Studios
Calm Raindrops
Sol Good Network
Community discussion